Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pathologist
100%
KRAS mutation
100%
Colorectal Cancer
100%
Tumor Cells
66%
Tumor
50%
Tumor Cellularity
50%
Neoadjuvant Therapy
33%
Quality Assessment
33%
Neoplastic Tissue
33%
High Sensitivity
16%
Next-generation Sequencing Platforms
16%
Software Program
16%
Mutant Alleles
16%
Detection Accuracy
16%
Previous Treatment
16%
Formalin-fixed Paraffin-embedded Tissue
16%
Chemotherapy
16%
Tumor Heterogeneity
16%
Retrospective Analysis
16%
Molecular Diagnostics
16%
Response Predictors
16%
Metastatic Colorectal Cancer (mCRC)
16%
Codon 12
16%
Clinical Detection
16%
Mutant Allele Frequency
16%
Anti-epidermal Growth Factor Receptor Monoclonal Antibodies
16%
Pyrogram
16%
Pyrosequencing Assay
16%
Codon 13
16%
KRAS mutation Detection
16%
Medicine and Dentistry
Neoplasm
100%
Pathologist
100%
Colorectal Carcinoma
100%
Tumor Cell
66%
Neoadjuvant Therapy
33%
Codon
33%
Allele
16%
Monoclonal Antibody
16%
Rectum Cancer
16%
Gene Frequency
16%
Molecular Diagnosis
16%
Next Generation Sequencing
16%
Metastatic Colorectal Cancer
16%
Glucose Test
16%
Formaldehyde
16%
Pyrosequencing
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Colorectal Carcinoma
100%
Chemotherapy
10%
Epidermal Growth Factor Receptor
10%
Monoclonal Antibody
10%
Formaldehyde
10%
Metastatic Colorectal Cancer
10%
Rectum Cancer
10%
Biochemistry, Genetics and Molecular Biology
KRAS
100%
Codon
28%
Next Generation Sequencing
14%
Allele
14%
Gene Frequency
14%
Glucose Test
14%
Glucose Tolerance Test
14%
Monoclonal Antibody
14%
Epidermal Growth Factor Receptor
14%
Pyrosequencing
14%